Number of drugs provided by the Pharmaceutical Benefits Scheme and mortality and hospital utilization in Australia, 2002-2019
We analyze the relationship between long-run changes in the drugs provided by the Pharmaceutical Benefits Scheme (PBS) and mortality and hospital utilization in Australia, by analyzing the correlation across diseases between the change in the number of drugs used to treat the disease provided and th...
Saved in:
Main Author: | Frank R. Lichtenberg (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HIV treatment regimens and adherence to national guidelines in Australia: an analysis of dispensing data from the Australian pharmaceutical benefits scheme
by: Nila J. Dharan, et al.
Published: (2019) -
Retrospective comparison of Australia's Pharmaceutical Benefits Scheme claims data with prescription data in HER2-positive early breast cancer patients, 2008-2012
by: Carole Harris, et al.
Published: (2017) -
The impact of pharmaceutical innovation on the burden of disease in Canada, 2000-2016
by: Frank R. Lichtenberg
Published: (2019) -
Mortality in residents of the urban and rural areas of Mexico, 2002-2019
by: Debanhi Martínez-Téllez, et al.
Published: (2023) -
Capture of systemic anticancer medicines in Pharmaceutical Benefits Scheme (PBS) data likely higher than previously reported
by: Dominique L Favell, et al.
Published: (2020)